These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29172777)

  • 1. A novel tumor-activated ALA fusion protein for specific inhibition on the growth and invasion of breast cancer cells MDA-MB-231.
    Liu X; Liu X; Sunchen S; Liu M; Shen C; Wu J; Zhao W; Yu B; Liu J
    Drug Deliv; 2017 Nov; 24(1):1811-1817. PubMed ID: 29172777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
    Holst-Hansen C; Johannessen B; Høyer-Hansen G; Rømer J; Ellis V; Brünner N
    Clin Exp Metastasis; 1996 May; 14(3):297-307. PubMed ID: 8674284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.
    Liang AL; Qian HL; Zhang TT; Zhou N; Wang HJ; Men XT; Qi W; Zhang PP; Fu M; Liang X; Lin C; Liu YJ
    Drug Des Devel Ther; 2015; 9():5671-86. PubMed ID: 26527862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
    Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition of MDA-MB-231 cell line by peptides designed based on uPA.
    Tarighi P; Khorramizadeh M; Madadkar-Sobhani A; Ostad S; Ghahremani M
    Acta Med Iran; 2015 Jul; 53(7):403-7. PubMed ID: 26520626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway.
    Li H; Soria C; Griscelli F; Opolon P; Soria J; Yeh P; Legrand C; Vannier JP; Belin D; Perricaudet M; Lu H
    Hum Gene Ther; 2005 Oct; 16(10):1157-67. PubMed ID: 16218777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and activity analysis of a new fusion protein targeting ovarian cancer cells.
    Su M; Chang W; Wang D; Cui M; Lin Y; Wu S; Xu T
    Oncol Rep; 2015 Sep; 34(3):1337-44. PubMed ID: 26166362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth.
    Kunigal S; Lakka SS; Gondi CS; Estes N; Rao JS
    Int J Cancer; 2007 Nov; 121(10):2307-16. PubMed ID: 17657740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cancer cell growth by Tangeretin flavone in drug-resistant MDA-MB-231 human breast carcinoma cells is facilitated via targeting cell apoptosis, cell cycle phase distribution, cell invasion and activation of numerous Caspases.
    Fan S; Xu H; Liu H; Hu Z; Xiao J; Liu H
    J BUON; 2019; 24(4):1532-1537. PubMed ID: 31646804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evodiamine induces apoptosis and inhibits metastasis in MDA‑MB-231 human breast cancer cells in vitro and in vivo.
    Du J; Wang XF; Zhou QM; Zhang TL; Lu YY; Zhang H; Su SB
    Oncol Rep; 2013 Aug; 30(2):685-94. PubMed ID: 23708383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and purification of recombinant ATF-mellitin, a new type fusion protein targeting ovarian cancer cells, in P. pastoris.
    Su M; Chang W; Zhang K; Cui M; Wu S; Xu T
    Oncol Rep; 2016 Feb; 35(2):1179-85. PubMed ID: 26718643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisatracurium inhibits the proliferation, migration and invasion of breast cancer cells by regulating the expression of miR-3174.
    Yang X; Ma W
    Cell Mol Biol (Noisy-le-grand); 2020 Sep; 66(6):1-7. PubMed ID: 33040777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.
    Moreau M; Mourah S; Dosquet C
    Int J Cancer; 2011 Mar; 128(6):1280-92. PubMed ID: 20473943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion.
    Guo Y; Pakneshan P; Gladu J; Slack A; Szyf M; Rabbani SA
    J Biol Chem; 2002 Nov; 277(44):41571-9. PubMed ID: 12198113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urokinase is a negative modulator of Egf-dependent proliferation and motility in the two breast cancer cell lines MCF-7 and MDA-MB-231.
    Kozlova N; Samoylenko A; Drobot L; Kietzmann T
    Mol Carcinog; 2016 Feb; 55(2):170-81. PubMed ID: 25641046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor Effects of Ruyiping on Cell Growth and Metastasis in Breast Cancer.
    Li Z; Sun X; Liu X; Sun Z; Li J
    Cancer Biother Radiopharm; 2019 Jun; 34(5):297-305. PubMed ID: 30901274
    [No Abstract]   [Full Text] [Related]  

  • 17. The Enhanced Cytotoxic Effects of the p28-Apoptin Chimeric Protein As A Novel Anti-Cancer Agent on Breast Cancer Cell Lines.
    Noei A; Nili-Ahmadabadi A; Soleimani M
    Drug Res (Stuttg); 2019 Feb; 69(3):144-150. PubMed ID: 30060264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new class of orthosteric uPAR·uPA small-molecule antagonists are allosteric inhibitors of the uPAR·vitronectin interaction.
    Liu D; Zhou D; Wang B; Knabe WE; Meroueh SO
    ACS Chem Biol; 2015 Jun; 10(6):1521-34. PubMed ID: 25671694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High glucose and insulin enhance uPA expression, ROS formation and invasiveness in breast cancer-derived cells.
    Flores-López LA; Martínez-Hernández MG; Viedma-Rodríguez R; Díaz-Flores M; Baiza-Gutman LA
    Cell Oncol (Dordr); 2016 Aug; 39(4):365-78. PubMed ID: 27106722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells.
    Amir S; Margaryan NV; Odero-Marah V; Khalkhali-Ellis Z; Hendrix MJ
    Cancer Biol Ther; 2005 Apr; 4(4):400-6. PubMed ID: 15846059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.